Rachel Wong

机构：Epworth Hospital, Eastern Health, Monash University · ORCID：0000-0002-4926-5689

发表论文 227 篇 · 总被引 9188 次 · h-index 29

代表论文

• Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial (2023 · The Lancet Oncology · 被引 698)
• Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial (2025 · Nature Medicine · 被引 129)
• Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial (2025 · Nature Medicine · 被引 76)
• Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study. (2024 · Journal of Clinical Oncology · 被引 44)
• Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer (2023 · Cell Reports Medicine · 被引 43)
• The potential role of serial circulating tumor DNA (ctDNA) testing after upfront surgery to guide adjuvant chemotherapy for early stage pancreatic cancer: The AGITG DYNAMIC-Pancreas trial. (2024 · Journal of Clinical Oncology · 被引 25)